Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Role of Neurotransmitters in Memory

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Exploring drug repurposing for monkeypox virus: A structural and computational approach.

Journal of Taibah University Medical Sciences·2026

Same author

Corrigendum to in vivo effects of a selected thiourea derivative 1-(2-chlorobenzoyl)-3-(2,3-dichlorophenyl) against nociception, inflammation and gastric ulcerogenicity: Biochemical, histopathological and in silico approaches [Biomed. Pharmacother. 174 (2024) 116544].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same author

Exploring the potential of multiple receptors overexpressed on glioblastoma cells as biomarkers for the targeted therapy; a review.

Therapeutic delivery·2026

Same author

Carbon halogen bond dissociation energy predictions through automated machine learning pipeline.

Scientific reports·2026

Same author

Design, synthesis, enzymatic and <i>in vivo</i> antihyperglycemic activity evaluation of 1,3,4-oxadiazole derivatives targeting multiple pathways in type 2 diabetes.

RSC advances·2026

Same author

Natural compounds from Fernandoa adenophylla (Wall. ex G.Don) Steenis as beta-secretase 1 and monoamine oxidase-b inhibitors: in vitro and computational evidence.

Journal of computer-aided molecular design·2026

Search research articles

Video Experimental Relacionado

Updated: Sep 9, 2025

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices

Published on: April 11, 2018

Elementos clave implicados en la progresión de la enfermedad de Alzheimer

Dania Khalid¹, Amber Afroz¹, Hammad Ismail¹

¹Department of Biochemistry and Biotechnology, University of Gujrat, Gujrat, Pakistan.

Central nervous system agents in medicinal chemistry

|September 5, 2025

Resumen

La enfermedad de Alzheimer (EA) implica un deterioro cognitivo debido a anomalías en las proteínas y desequilibrios en los neurotransmisores. La investigación explora los productos naturales y los vínculos con la diabetes para posibles estrategias terapéuticas.

Palabras clave:

La enfermedad de Alzheimer Acetilcolina esterasa y sus derivados Proteína beta amiloide La dopamina también productos vegetales naturales.y la serotonina

Más Videos Relacionados

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices

Published on: April 11, 2018

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

Área de la Ciencia:

La neurociencia
La bioquímica
La genética

Sus antecedentes:

La enfermedad de Alzheimer (EA) es un trastorno neurodegenerativo progresivo que afecta las funciones cognitivas, particularmente en personas mayores de 60 años, con una incidencia creciente en adultos más jóvenes.
La causa exacta de la enfermedad de Alzheimer sigue siendo desconocida, lo que dificulta el desarrollo de fármacos específicos.
Los factores clave implicados incluyen la proteína tau alterada, el beta amiloide, los receptores colinérgicos, los desequilibrios de los neurotransmisores (dopamina, serotonina), la disfunción mitocondrial y la inflamación.

Objetivo del estudio:

Revisar las múltiples facetas de la base biológica de la enfermedad de Alzheimer.
Resaltar las áreas de investigación emergentes, incluida la conexión entre la EA y la diabetes mellitus.
Explorar el potencial de los productos naturales en la terapia de la enfermedad de Alzheimer.

Principales métodos:

Revisión de la literatura científica existente y de los análisis de transcriptómica y proteómica.
Investigación de la desregulación genética y proteica en la enfermedad de Alzheimer.
Examen de las vías celulares implicadas en la patogénesis de la enfermedad de Alzheimer.

Principales resultados:

Identificación de genes y proteínas interconectados implicados en la EA a través de la transcriptómica y la proteómica.
Evidencia que sugiere un vínculo entre la enfermedad de Alzheimer y la diabetes mellitus.
Reconocimiento de la disfunción mitocondrial, la señalización del calcio y la inflamación como contribuyentes significativos.

Conclusiones:

La patogénesis de la enfermedad de Alzheimer es compleja, e implica alteraciones genéticas, proteómicas y de las vías celulares.
El vínculo con la diabetes mellitus presenta una nueva vía de investigación.
Los productos naturales son prometedores como agentes terapéuticos futuros para mejorar la enfermedad de Alzheimer y sus síntomas.